North American Morning Briefing: Stock Futures -2- morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
Wedbush reissued their outperform rating on shares of Tyra Biosciences (NASDAQ:TYRA – Free Report) in a research note published on Friday, Benzinga reports. The brokerage currently has a $27.00 price objective on the stock. Wedbush also issued estimates for Tyra Biosciences’ Q2 2024 earnings at ($0.38) EPS. Separately, HC Wainwright upped their price objective on […]
Tyra Biosciences (NASDAQ:TYRA – Free Report) had its target price boosted by HC Wainwright from $17.00 to $20.00 in a report released on Friday morning, MarketBeat reports. HC Wainwright currently has a buy rating on the stock. Separately, Wedbush initiated coverage on shares of Tyra Biosciences in a research report on Thursday, June 29th. They […]
Tyra Biosciences (TYRA) Outperform Rating Reaffirmed at Wedbush themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that.